Valuation
- Market cap
- 56,000
- Revenue TTM
- $0
- Net income TTM
- $-1,170,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 31,338
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 559,281,000
- Stochastic %K
- —
- Beta
- 0.61
- Analysts
- —
- Price target
- $0.25
Company profile
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly k...
Show more
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 212 541 2405
- Website
- https://mhtx.com
- Address
- 244 Fifth Avenue, Suite 2341, New York, United States
Latest news
No headlines yet.
